Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S1.79
P/E—
Fwd P/E12.10
PEG1.22
52W— – —
RSI—
Target$93.92 (+7.4%)
Beta0.69
Div—
Loading chart…
RSI ()
Loading patterns…
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 46
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral
Key Signals 1
▲ Double Bottom
Major reversal
2026-07-16 · $80.6
Two lows ~$73.90 — bullish reversal confirmed
Learn more →
Momentum Signals 10
▲ Bull Flag
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$93.92
+7.4% upside
Low $70
—
High $113
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
54.78%Last 12 Months
Operating Margin
9.78%Last 12 Months
Return on Equity
33.96%Last 12 Months
Revenue Growth
2.20%Year over Year
Free Cash Flow
489.00MLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
110.31Most Recent Quarter
Current Ratio
1.02Most Recent Quarter
Cash
403.00MMost Recent Quarter
Total Debt
5.30BMost Recent Quarter
Net Debt
—Most Recent Quarter
How SOLV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 14.89B |
| Enterprise Value | 19.78B |
| Trailing P/E | 10.72 |
| Forward P/E | 12.10 |
| PEG Ratio (5yr) | 1.22 |
| Price/Sales (ttm) | 1.79 |
| Price/Book (mrq) | 3.10 |
| EV/Revenue | 2.38 |
| EV/EBITDA | 17.36 |
Share Statistics
| Avg Vol (3m) | 1.17M |
| Shares Outstanding | 170.22M |
| Float | 144.09M |
| % Held by Insiders | 15.34% |
| % Held by Institutions | 75.89% |
| Short Ratio | 3.68 |
| Short % of Float | 2.98% |
Profitability
| Gross Margin | 54.78% |
| Operating Margin (ttm) | 9.78% |
| Profit Margin | 17.26% |
| Return on Assets (ttm) | 2.70% |
| Return on Equity (ttm) | 33.96% |
Income Statement
| Revenue (ttm) | 8.31B |
| Revenue Growth (yoy) | 2.20% |
| Gross Profit (ttm) | 4.55B |
| EBITDA | 1.14B |
| Net Income (ttm) | 1.43B |
| Diluted EPS (ttm) | 8.16 |
| EPS Growth (yoy) | 3.90% |
Balance Sheet
| Total Cash (mrq) | 403.00M |
| Total Debt (mrq) | 5.30B |
| Debt / Equity (mrq) | 110.31 |
| Current Ratio (mrq) | 1.02 |
| Book Value / Share | 28.22 |
| Operating CF (ttm) | 209.00M |
| Free Cash Flow (ttm) | 489.00M |
Trading & Dividends
| Beta (5Y) | 0.69 |
| 50-Day MA | 84.67 |
| 200-Day MA | 77.56 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
No dividend history available for SOLV.
Ownership Breakdown
Institutional 75.89%
Insider 15.34%
Public 8.8%
Short Interest
2.98% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in SOLV in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|